{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T06:13:16Z","timestamp":1784441596592,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_2019_2009"],"award-info":[{"award-number":["IIG_2019_2009"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["17\/0005587"],"award-info":[{"award-number":["17\/0005587"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218495\/Z\/19\/Z"],"award-info":[{"award-number":["218495\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00011\/1"],"award-info":[{"award-number":["MC_UU_00011\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00011\/4"],"award-info":[{"award-number":["MC_UU_00011\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013743","name":"World Cancer Research Fund International","doi-asserted-by":"publisher","award":["202802\/Z\/16\/Z"],"award-info":[{"award-number":["202802\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100013743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ebiom.2023.104503","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T18:15:31Z","timestamp":1677780931000},"page":"104503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-9691","authenticated-orcid":false,"given":"Madeleine L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-5120","authenticated-orcid":false,"given":"Caroline J.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104503_bib1","series-title":"IDF diabetes atlas, 9th ed. [Internet]","year":"2019"},{"key":"10.1016\/j.ebiom.2023.104503_bib2","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","author":"Khan","year":"2020","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104503_bib3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104503_bib4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A\u00a0comprehensive 1000 genomes\u2013based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib5","doi-asserted-by":"crossref","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104503_bib6","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/jc.2018-00546","article-title":"Altered asparagine and glutamate homeostasis precede coronary artery disease and type 2 diabetes","volume":"103","author":"Ottosson","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104503_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diabet.2018.02.006","article-title":"Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: a cross-sectional study of PREDIMED trial participants","volume":"45","author":"Urpi-Sarda","year":"2019","journal-title":"Diabetes Metab"},{"issue":"39","key":"10.1016\/j.ebiom.2023.104503_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/dc15-2251","article-title":"Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis","author":"Guasch-Ferr\u00e9","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2023.104503_bib9","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts","author":"Ahola-Olli","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-2096-8","article-title":"Metabolic signature of obesity-associated insulin resistance and type 2 diabetes","volume":"17","author":"Al-Sulaiti","year":"2019","journal-title":"J\u00a0Transl Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104503_bib11","doi-asserted-by":"crossref","first-page":"e0234970","DOI":"10.1371\/journal.pone.0234970","article-title":"Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes","volume":"15","author":"Concepcion","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2023.104503_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.609806","article-title":"Distinctive metabolomics patterns associated with insulin resistance and type 2 diabetes mellitus","volume":"7","author":"Gu","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104503_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11306-017-1239-2","article-title":"Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study","volume":"13","author":"Liu","year":"2017","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-8587(13)70143-8","article-title":"Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome","volume":"2","author":"Roberts","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104503_bib15","doi-asserted-by":"crossref","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","article-title":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting","volume":"5","author":"Suhre","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-020-01653-7","article-title":"Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity","volume":"16","author":"Bos","year":"2020","journal-title":"Metabolomics"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104503_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1210\/clinem\/dgz240","article-title":"Metabolomics signatures in type 2 diabetes: a systematic review and integrative analysis","volume":"105","author":"Sun","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib18","article-title":"Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF\/MS-based metabolomics approach","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104503_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2019-315485","article-title":"Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease","volume":"106","author":"Smith","year":"2020","journal-title":"Heart"},{"issue":"34","key":"10.1016\/j.ebiom.2023.104503_bib20","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1093\/eurheartj\/ehz235","article-title":"Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease","volume":"40","author":"Tzoulaki","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ebiom.2023.104503_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2019.02.030","article-title":"Metabolomics profiling and pathway analysis of human plasma and urine reveal further insights into the multifactorial nature of coronary artery disease","volume":"493","author":"Amin","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104503_bib22","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1039\/C6MB00339G","article-title":"An LC-MS based untargeted metabolomics study identified novel biomarkers for coronary heart disease","volume":"12","author":"Li","year":"2016","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.ebiom.2023.104503_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jprot.2015.03.011","article-title":"Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach","volume":"127","author":"Basak","year":"2015","journal-title":"J\u00a0Proteonomics"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104503_bib24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jacc.2016.06.044","article-title":"Comprehensive metabolomic characterization of coronary artery diseases","volume":"68","author":"Fan","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104503_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cells10050980","article-title":"Metabolic signatures in coronary artery disease: results from the BioHEART-CT study","volume":"10","author":"Vernon","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104503_bib26","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/ATVBAHA.118.312236","article-title":"Metabolomic pattern predicts incident coronary heart disease","volume":"39","author":"Wang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib27","article-title":"Large-scale metabolomic analysis reveals potential biomarkers for early stage coronary atherosclerosis","volume":"7","author":"Gao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104503_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpba.2016.06.040","article-title":"Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF\/MS","volume":"129","author":"Xu","year":"2016","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"18","key":"10.1016\/j.ebiom.2023.104503_bib29","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/eurheartj\/ehs020","article-title":"High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis","volume":"33","author":"Wurtz","year":"2012","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104503_bib30","doi-asserted-by":"crossref","first-page":"e0237579","DOI":"10.1371\/journal.pone.0237579","article-title":"Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease","volume":"15","author":"Mehta","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104503_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163","author":"Shah","year":"2012","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-01865-2","article-title":"Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial","volume":"21","author":"Karagiannidis","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104503_bib34","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease","volume":"60","author":"Ference","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104503_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104503_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib37","doi-asserted-by":"crossref","first-page":"e1003062","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1373\/clinchem.2018.296806","article-title":"Can Mendelian randomization shift into reverse gear?","volume":"65","author":"Holmes","year":"2019","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104503_bib39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/dc19-2348","article-title":"Early metabolic features of genetic liability to type 2 diabetes: cohort study with repeated metabolomics across early life","volume":"43","author":"Bell","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2023.104503_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.12688\/wellcomeopenres.14788.2","article-title":"Coronary artery disease, genetic risk and the metabolome in young individuals","volume":"3","author":"Battram","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ebiom.2023.104503_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaa266","article-title":"Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations","author":"Hartwig","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104503_bib42","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","article-title":"Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants","volume":"54","author":"Aragam","year":"2022","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104503_bib43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/eurheartj\/ehx254","article-title":"UK Biobank: opportunities for cardiovascular research","volume":"40","author":"Littlejohns","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41467-018-08219-1","article-title":"Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis","volume":"10","author":"Haworth","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib45","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex\u00a0diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104503_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies","volume":"186","author":"W\u00fcrtz","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2023.104503_bib47","series-title":"MRC IEU UK Biobank GWAS pipeline version 2. data.bris","author":"Mitchell","year":"2019"},{"issue":"32","key":"10.1016\/j.ebiom.2023.104503_bib48","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104503_bib49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","article-title":"Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase","volume":"67","author":"W\u00fcrtz","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9965","key":"10.1016\/j.ebiom.2023.104503_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104503_bib51","doi-asserted-by":"crossref","first-page":"100457","DOI":"10.1016\/j.lanepe.2022.100457","article-title":"Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: a multivariable Mendelian randomization study","volume":"21","author":"Bell","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104503_bib52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.ebiom.2023.104503_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104503_bib55","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104503_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104503_bib56","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104503_bib57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10654-018-0424-6","article-title":"Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates","volume":"33","author":"Burgess","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104503_bib58","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104503_bib59","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104503_bib60","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2337\/db16-0418","article-title":"BMI as a modifiable risk factor for type 2 diabetes: refining and understanding causal estimates using mendelian randomization","volume":"65","author":"Corbin","year":"2016","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104503_bib61","doi-asserted-by":"crossref","first-page":"e1001765","DOI":"10.1371\/journal.pmed.1001765","article-title":"Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change","volume":"11","author":"W\u00fcrtz","year":"2014","journal-title":"PLoS Med"},{"issue":"7280","key":"10.1016\/j.ebiom.2023.104503_bib62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.322.7280.226","article-title":"Sifting the evidence\u2014what\u2019s wrong with significance tests?","volume":"322","author":"Sterne","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104503_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104503_bib64","doi-asserted-by":"crossref","first-page":"e0207947","DOI":"10.1371\/journal.pone.0207947","article-title":"Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly \u2013 a meta-analysis","volume":"13","author":"Solym\u00e1r","year":"2018","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.ebiom.2023.104503_bib65","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000146898.06923.80","article-title":"Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"110","author":"M\u00e4rz","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrd1658","article-title":"HDL as a target in the treatment of atherosclerotic cardiovascular disease","volume":"4","author":"Linsel-Nitschke","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"9841","key":"10.1016\/j.ebiom.2023.104503_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104503_bib68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/2047487318816495","article-title":"Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: a systematic review and meta-analysis","volume":"26","author":"Riaz","year":"2019","journal-title":"Eur J Prevent Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/dyaa016","article-title":"Correlation without a cause: an epidemiological odyssey","volume":"49","author":"Davey Smith","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib70","doi-asserted-by":"crossref","first-page":"e000438","DOI":"10.1136\/bmjdrc-2017-000438","article-title":"Statin use and risk of developing diabetes: results from the Diabetes Prevention Program","volume":"5","author":"Crandall","year":"2017","journal-title":"BMJ Open Diabet Res Care"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104503_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104503_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104503_bib73","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc17-1642","article-title":"Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation","volume":"40","author":"Wang","year":"2017","journal-title":"Diabetes Care"},{"issue":"9822","key":"10.1016\/j.ebiom.2023.104503_bib74","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis","volume":"379","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104503_bib75","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104503_bib76","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2337\/dc11-0447","article-title":"Obesity and type 2 diabetes: what can be unified and what needs to be individualized?","volume":"34","author":"Eckel","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104503_bib77","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41431-018-0180-9","article-title":"Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits","volume":"26","author":"Lv","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ebiom.2023.104503_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.809445","article-title":"Smoking status and type 2 diabetes, and cardiovascular disease: a comprehensive analysis of shared genetic etiology and causal relationship","volume":"13","author":"Chi","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104503_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002814","article-title":"Alcohol consumption and cardiovascular disease","volume":"13","author":"Larsson","year":"2020","journal-title":"Circ Genom Precis Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:23:07Z","timestamp":1762456987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":79,"alternative-id":["S2352396423000683"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104503","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.13.22273833","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104503"}}